{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:22:05Z","timestamp":1749666125909,"version":"3.38.0"},"reference-count":87,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Vaccinia virus (VACV) is a useful model system for understanding the immune response to a complex pathogen. Proteome-wide Ab profiling studies reveal the humoral response to be strongly biased toward virion-associated Ags, and several membrane proteins induce Ab-mediated protection against VACV challenge in mice. Some studies have indicated that the CD4 response is also skewed toward proteins with virion association, whereas the CD8 response is more biased toward proteins with early expression. In this study, we have leveraged a VACV strain Western Reserve (VACV-WR) plasmid expression library, produced previously for proteome microarrays for Ab profiling, to make a solubilized full VACV-WR proteome for T cell Ag profiling. Splenocytes from VACV-WR\u2013infected mice were assayed without prior expansion against the soluble proteome in assays for Th1 and Th2 signature cytokines. The response to infection was polarized toward a Th1 response, with the distribution of reactive T cell Ags comprising both early and late VACV proteins. Interestingly, the proportions of different functional subsets were similar to that present in the whole proteome. In contrast, the targets of Abs from the same mice were enriched for membrane and other virion components, as described previously. We conclude that a \u201cnonbiasing\u201d approach to T cell Ag discovery reveals a T cell Ag profile in VACV that is broader and less skewed to virion association than the Ab profile. The T cell Ag mapping method developed in the present study should be applicable to other organisms where expressible \u201cORFeome\u201d libraries are also available, and it is readily scalable for larger pathogens.<\/jats:p>","DOI":"10.4049\/jimmunol.1400663","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T04:13:20Z","timestamp":1405397600000},"page":"1812-1827","source":"Crossref","is-referenced-by-count":4,"title":["T Cell Antigen Discovery Using Soluble Vaccinia Proteome Reveals Recognition of Antigens with Both Virion and Nonvirion Association"],"prefix":"10.1093","volume":"193","author":[{"given":"D Huw","family":"Davies","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, University of California , Irvine, Irvine, CA 92697"},{"name":"Antigen Discovery, Inc. , Irvine, CA 92618"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sookhee","family":"Chun","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, University of California , Irvine, Irvine, CA 92697"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Hermanson","sequence":"additional","affiliation":[{"name":"Antigen Discovery, Inc. , Irvine, CA 92618"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo Anne","family":"Tucker","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, School of Medicine, University of California , Irvine, Irvine, CA 92697"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarti","family":"Jain","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, University of California , Irvine, Irvine, CA 92697"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, University of California , Irvine, Irvine, CA 92697"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozelyn","family":"Pablo","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, University of California , Irvine, Irvine, CA 92697"},{"name":"Antigen Discovery, Inc. , Irvine, CA 92618"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip L","family":"Felgner","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, University of California , Irvine, Irvine, CA 92697"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowu","family":"Liang","sequence":"additional","affiliation":[{"name":"Antigen Discovery, Inc. , Irvine, CA 92618"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,8,15]]},"reference":[{"key":"2025030707303511200_r1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1517\/14712598.4.6.767","article-title":"Immunome-derived vaccines","volume":"4","author":"De Groot","year":"2004","journal-title":"Expert Opin. Biol. Ther."},{"key":"2025030707303511200_r2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpara.2010.08.002","article-title":"Plasmodium immunomics","volume":"41","author":"Doolan","year":"2011","journal-title":"Int. J. Parasitol."},{"key":"2025030707303511200_r3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/omi.2010.0127","article-title":"Designing the next generation of vaccines for global public health","volume":"15","author":"Bagnoli","year":"2011","journal-title":"OMICS"},{"key":"2025030707303511200_r4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(86)90019-X","article-title":"The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides","volume":"44","author":"Townsend","year":"1986","journal-title":"Cell"},{"key":"2025030707303511200_r5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2567.2010.03300.x","article-title":"Major histocompatibility complex class I binding predictions as a tool in epitope discovery","volume":"130","author":"Lundegaard","year":"2010","journal-title":"Immunology"},{"key":"2025030707303511200_r6","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.2174\/138161209789105171","article-title":"HLA-DR: molecular insights and vaccine design","volume":"15","author":"Stern","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"2025030707303511200_r7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jim.2010.10.010","article-title":"Applications for T-cell epitope queries and tools in the Immune Epitope Database and Analysis Resource","volume":"374","author":"Kim","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"2025030707303511200_r8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/1745-7580.1000040","article-title":"A model for collaborative curation, the IEDB and ChEBI curation of non-peptidic epitopes","volume":"7","author":"Vita","year":"2011","journal-title":"Immunome Res."},{"key":"2025030707303511200_r9","doi-asserted-by":"crossref","first-page":"D854","DOI":"10.1093\/nar\/gkp1004","article-title":"The immune epitope database 2.0","volume":"38","author":"Vita","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"2025030707303511200_r10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1074\/mcp.R300013-MCP200","article-title":"Immunoproteomics: mass spectrometry-based methods to study the targets of the immune response","volume":"3","author":"Purcell","year":"2004","journal-title":"Mol. Cell. Proteomics"},{"key":"2025030707303511200_r11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1586\/14789450.3.6.653","article-title":"Contribution of mass spectrometry-based proteomics to immunology","volume":"3","author":"Hillen","year":"2006","journal-title":"Expert Rev. Proteomics"},{"key":"2025030707303511200_r12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4161\/hv.6.8.12299","article-title":"Development of a Chlamydia trachomatis T cell vaccine","volume":"6","author":"Karunakaran","year":"2010","journal-title":"Hum. Vaccin."},{"key":"2025030707303511200_r13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.1546328","article-title":"Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry","volume":"255","author":"Hunt","year":"1992","journal-title":"Science"},{"key":"2025030707303511200_r14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.vaccine.2009.09.126","article-title":"Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development","volume":"28","author":"Johnson","year":"2009","journal-title":"Vaccine"},{"key":"2025030707303511200_r15","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.1128\/JVI.00453-08","article-title":"An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling","volume":"82","author":"Jing","year":"2008","journal-title":"J. Virol."},{"key":"2025030707303511200_r16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jim.2009.05.011","article-title":"ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans","volume":"347","author":"Jing","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"2025030707303511200_r17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chom.2011.01.007","article-title":"TH17-based vaccine design for prevention of Streptococcus pneumoniae colonization","volume":"9","author":"Moffitt","year":"2011","journal-title":"Cell Host Microbe"},{"key":"2025030707303511200_r18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-1759(01)00436-7","article-title":"T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes","volume":"256","author":"Turner","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"2025030707303511200_r19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12026-009-8103-z","article-title":"An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis","volume":"45","author":"Valentino","year":"2009","journal-title":"Immunol. Res."},{"key":"2025030707303511200_r20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2567.2010.03387.x","article-title":"Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets","volume":"132","author":"Valentino","year":"2011","journal-title":"Immunology"},{"key":"2025030707303511200_r21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jim.2011.08.007","article-title":"A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens","volume":"373","author":"Valentino","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"2025030707303511200_r22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1046-2023(02)00344-4","article-title":"Expression cloning for the discovery of viral antigens and epitopes recognized by T cells","volume":"29","author":"Koelle","year":"2003","journal-title":"Methods"},{"key":"2025030707303511200_r23","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.4049\/jimmunol.166.6.4049","article-title":"CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells","volume":"166","author":"Koelle","year":"2001","journal-title":"J. Immunol."},{"key":"2025030707303511200_r24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/CMR.16.1.96-113.2003","article-title":"Recent progress in herpes simplex virus immunobiology and vaccine research","volume":"16","author":"Koelle","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"2025030707303511200_r25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2217\/fmb.09.110","article-title":"Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens","volume":"5","author":"Moutaftsi","year":"2010","journal-title":"Future Microbiol."},{"key":"2025030707303511200_r26","doi-asserted-by":"crossref","first-page":"G21","DOI":"10.1016\/j.vaccine.2009.10.011","article-title":"Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens","volume":"27","author":"Sette","year":"2009","journal-title":"Vaccine"},{"key":"2025030707303511200_r27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.vaccine.2011.11.021","article-title":"Measurement of antibody responses to modified vaccinia virus Ankara (MVA) and Dryvax using proteome microarrays and development of recombinant protein ELISAs","volume":"30","author":"Hermanson","year":"2012","journal-title":"Vaccine"},{"key":"2025030707303511200_r28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/CVI.05521-11","article-title":"Failure of the smallpox vaccine to develop a skin lesion in vaccinia virus-naive individuals is related to differences in antibody profiles before vaccination, not after","volume":"19","author":"Tan","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"2025030707303511200_r29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1073\/pnas.0408782102","article-title":"Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery","volume":"102","author":"Davies","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030707303511200_r30","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1002\/pmic.200800194","article-title":"Profiling humoral immune responses to P. falciparum infection with protein microarrays","volume":"8","author":"Doolan","year":"2008","journal-title":"Proteomics"},{"key":"2025030707303511200_r31","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/pmic.200600985","article-title":"Immunodominant Francisella tularensis antigens identified using proteome microarray","volume":"7","author":"Eyles","year":"2007","journal-title":"Proteomics"},{"key":"2025030707303511200_r32","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1073\/pnas.1006594107","article-title":"Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030707303511200_r33","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.163.12.6448","article-title":"Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling","volume":"163","author":"Brewer","year":"1999","journal-title":"J. Immunol."},{"key":"2025030707303511200_r34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0008-8749(89)90011-7","article-title":"Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses","volume":"121","author":"Grun","year":"1989","journal-title":"Cell. Immunol."},{"key":"2025030707303511200_r35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1440-1711.1998.00756.x","article-title":"Functional aspects of iscoms","volume":"76","author":"Morein","year":"1998","journal-title":"Immunol. Cell Biol."},{"key":"2025030707303511200_r36","first-page":"199","article-title":"CpG DNA switches on Th1 immunity and modulates antigen-presenting cell function","volume":"247","author":"Chu","year":"2000","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"2025030707303511200_r37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"2025030707303511200_r38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-1759(98)00015-5","article-title":"The need for IgG2c specific antiserum when isotyping antibodies from C57BL\/6 and NOD mice","volume":"212","author":"Martin","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"2025030707303511200_r39","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J. Virol."},{"key":"2025030707303511200_r40","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1021\/pr200619r","article-title":"Systems biology approach predicts antibody signature associated with Brucella melitensis infection in humans","volume":"10","author":"Liang","year":"2011","journal-title":"J. Proteome Res."},{"key":"2025030707303511200_r41","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/pmic.200600926","article-title":"Proteome-wide analysis of the serological response to vaccinia and smallpox","volume":"7","author":"Davies","year":"2007","journal-title":"Proteomics"},{"key":"2025030707303511200_r42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"key":"2025030707303511200_r43","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.4049\/jimmunol.1202523","article-title":"CD4+ T cells provide intermolecular help to generate robust antibody responses in vaccinia virus-vaccinated humans","volume":"190","author":"Yin","year":"2013","journal-title":"J. Immunol."},{"key":"2025030707303511200_r44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.virol.2005.09.056","article-title":"Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host","volume":"345","author":"Fang","year":"2006","journal-title":"Virology"},{"key":"2025030707303511200_r45","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1215","article-title":"A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus","volume":"24","author":"Moutaftsi","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"2025030707303511200_r46","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/JVI.02152-12","article-title":"Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine","volume":"87","author":"Benhnia","year":"2013","journal-title":"J. Virol."},{"key":"2025030707303511200_r47","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/JVI.01706-07","article-title":"Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax","volume":"82","author":"Davies","year":"2008","journal-title":"J. Virol."},{"key":"2025030707303511200_r48","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat. Med."},{"key":"2025030707303511200_r49","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1128\/JVI.00116-06","article-title":"Obligatory requirement for antibody in recovery from a primary poxvirus infection","volume":"80","author":"Chaudhri","year":"2006","journal-title":"J. Virol."},{"key":"2025030707303511200_r50","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/jvi.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"Rodriguez","year":"1985","journal-title":"J. Virol."},{"key":"2025030707303511200_r51","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1006\/viro.1994.1405","article-title":"Identification of a vaccinia virus penetration protein","volume":"202","author":"Ichihashi","year":"1994","journal-title":"Virology"},{"key":"2025030707303511200_r52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"key":"2025030707303511200_r53","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/viro.1996.0337","article-title":"Neutralizing epitope on penetration protein of vaccinia virus","volume":"220","author":"Ichihashi","year":"1996","journal-title":"Virology"},{"key":"2025030707303511200_r54","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J. Virol."},{"key":"2025030707303511200_r55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/viro.2001.1131","article-title":"The A17L gene product of vaccinia virus is exposed on the surface of IMV","volume":"290","author":"Wallengren","year":"2001","journal-title":"Virology"},{"key":"2025030707303511200_r56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"key":"2025030707303511200_r57","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"P\u00fctz","year":"2006","journal-title":"Nat. Med."},{"key":"2025030707303511200_r58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2008.08.009","article-title":"Vaccinia virus entry\/fusion complex subunit A28 is a target of neutralizing and protective antibodies","volume":"380","author":"Nelson","year":"2008","journal-title":"Virology"},{"key":"2025030707303511200_r59","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J. Virol."},{"key":"2025030707303511200_r60","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1128\/JVI.01593-09","article-title":"Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5","volume":"83","author":"Benhnia","year":"2009","journal-title":"J. Virol."},{"key":"2025030707303511200_r61","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3851\/IMP1573","article-title":"Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model","volume":"15","author":"McCausland","year":"2010","journal-title":"Antivir. Ther. (Lond.)"},{"key":"2025030707303511200_r62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.virol.2010.05.025","article-title":"The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 protein","volume":"405","author":"Shinoda","year":"2010","journal-title":"Virology"},{"key":"2025030707303511200_r63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2011.06.029","article-title":"An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies","volume":"418","author":"Xu","year":"2011","journal-title":"Virology"},{"key":"2025030707303511200_r64","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1128\/JVI.00836-12","article-title":"Structural and biochemical characterization of the vaccinia virus envelope protein D8 and its recognition by the antibody LA5","volume":"86","author":"Matho","year":"2012","journal-title":"J. Virol."},{"key":"2025030707303511200_r65","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1743-422X-10-229","article-title":"Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response","volume":"10","author":"Paran","year":"2013","journal-title":"Virol. J."},{"key":"2025030707303511200_r66","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1016\/j.vaccine.2010.05.023","article-title":"Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection","volume":"28","author":"Rudraraju","year":"2010","journal-title":"Vaccine"},{"key":"2025030707303511200_r67","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/prca.200780113","article-title":"Analysis of the human immune response to vaccinia by use of a novel protein microarray suggests that antibodies recognize less than 10% of the total viral proteome","volume":"2","author":"Schmid","year":"2008","journal-title":"Proteomics Clin. Appl."},{"key":"2025030707303511200_r68","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1128\/JVI.02244-07","article-title":"Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine","volume":"82","author":"Benhnia","year":"2008","journal-title":"J. Virol."},{"key":"2025030707303511200_r69","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.vaccine.2013.06.046","article-title":"Proteins as T cell antigens: methods for high-throughput identification","volume":"31","author":"Grubaugh","year":"2013","journal-title":"Vaccine"},{"key":"2025030707303511200_r70","doi-asserted-by":"crossref","first-page":"e27666","DOI":"10.1371\/journal.pone.0027666","article-title":"Evaluation of approaches to identify the targets of cellular immunity on a proteome-wide scale","volume":"6","author":"Cardoso","year":"2011","journal-title":"PLoS ONE"},{"key":"2025030707303511200_r71","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.4049\/jimmunol.178.11.6814","article-title":"Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses","volume":"178","author":"Moutaftsi","year":"2007","journal-title":"J. Immunol."},{"key":"2025030707303511200_r72","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2008.04.018","article-title":"Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities","volume":"28","author":"Sette","year":"2008","journal-title":"Immunity"},{"key":"2025030707303511200_r73","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1371\/journal.ppat.0030144","article-title":"Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection","volume":"3","author":"Calvo-Calle","year":"2007","journal-title":"PLoS Pathog."},{"key":"2025030707303511200_r74","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1016\/j.vaccine.2009.06.018","article-title":"In silico-accelerated identification of conserved and immunogenic variola\/vaccinia T-cell epitopes","volume":"27","author":"Moise","year":"2009","journal-title":"Vaccine"},{"key":"2025030707303511200_r75","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20121517","article-title":"Revealing the role of CD4+ T cells in viral immunity","volume":"209","author":"Sant","year":"2012","journal-title":"J. Exp. Med."},{"key":"2025030707303511200_r76","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.coi.2012.01.014","article-title":"Helper T cell diversity and plasticity","volume":"24","author":"Nakayamada","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"2025030707303511200_r77","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-381300-8.00005-8","article-title":"The many face-lifts of CD4 T helper cells","volume":"107","author":"Mucida","year":"2010","journal-title":"Adv. Immunol."},{"key":"2025030707303511200_r78","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells","volume":"327","author":"O\u2019Shea","year":"2010","journal-title":"Science"},{"key":"2025030707303511200_r79","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines","volume":"201","author":"Tscharke","year":"2005","journal-title":"J. Exp. Med."},{"key":"2025030707303511200_r80","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1128\/JVI.01281-10","article-title":"Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response","volume":"84","author":"Yuen","year":"2010","journal-title":"J. Virol."},{"key":"2025030707303511200_r81","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3181\/00379727-114-28589","article-title":"Immunological specificity of the secondary response with dinitrophenylated proteins","volume":"114","author":"Ovary","year":"1963","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"2025030707303511200_r82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/eji.1830010104","article-title":"The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation","volume":"1","author":"Mitchison","year":"1971","journal-title":"Eur. J. Immunol."},{"key":"2025030707303511200_r83","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/2261257a0","article-title":"Role of thymus-derived lymphocytes in the secondary humoral immune response in mice","volume":"226","author":"Raff","year":"1970","journal-title":"Nature"},{"key":"2025030707303511200_r84","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1073\/pnas.0711573105","article-title":"Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes","volume":"105","author":"Assarsson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030707303511200_r85","doi-asserted-by":"crossref","first-page":"e2628","DOI":"10.1371\/journal.pone.0002628","article-title":"Comparative analysis of viral gene expression programs during poxvirus infection: a transcriptional map of the vaccinia and monkeypox genomes","volume":"3","author":"Rubins","year":"2008","journal-title":"PLoS ONE"},{"key":"2025030707303511200_r86","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.virol.2006.08.025","article-title":"Protein composition of the vaccinia virus mature virion","volume":"358","author":"Resch","year":"2007","journal-title":"Virology"},{"key":"2025030707303511200_r87","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.80.5.2127-2140.2006","article-title":"Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles","volume":"80","author":"Chung","year":"2006","journal-title":"J. Virol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/193\/4\/1812\/61496412\/1400663.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/193\/4\/1812\/61496412\/1400663.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:57:14Z","timestamp":1741334234000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/193\/4\/1812\/7960588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1400663","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"type":"print","value":"0022-1767"},{"type":"electronic","value":"1550-6606"}],"subject":[],"published-other":{"date-parts":[[2014,8]]},"published":{"date-parts":[[2014,8]]}}}